2q9i
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2q9i.jpg|left|200px]] | [[Image:2q9i.jpg|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2q9i", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | | | + | or leave the SCENE parameter empty for the default display. |
- | | | + | --> |
- | + | {{STRUCTURE_2q9i| PDB=2q9i | SCENE= }} | |
- | + | ||
- | + | ||
- | }} | + | |
'''Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.''' | '''Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.''' | ||
Line 27: | Line 24: | ||
[[Category: Doolittle, R F.]] | [[Category: Doolittle, R F.]] | ||
[[Category: Pandi, L.]] | [[Category: Pandi, L.]] | ||
- | [[Category: | + | [[Category: Alternative splicing]] |
- | [[Category: | + | [[Category: B-knob]] |
- | [[Category: | + | [[Category: Beta-hole]] |
- | [[Category: | + | [[Category: Blood clotting]] |
- | [[Category: | + | [[Category: Blood coagulation]] |
- | [[Category: | + | [[Category: Coiled coil]] |
- | [[Category: | + | [[Category: Disease mutation]] |
- | [[Category: | + | [[Category: Fibrin clot]] |
- | [[Category: | + | [[Category: Glycoprotein]] |
- | [[Category: | + | [[Category: Phosphoprotein]] |
- | [[Category: | + | [[Category: Polymorphism]] |
- | [[Category: | + | [[Category: Pyrrolidone carboxylic acid]] |
- | [[Category: | + | [[Category: Secreted]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 14:34:43 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 11:34, 4 May 2008
Crystal Structure of D-Dimer from Human Fibrin Complexed with Met-His-Arg-Pro-Tyr-amide.
Overview
In a recent report, we showed that alanine can replace glycine at the amino terminus of synthetic B-knobs that bind to human fibrin(ogen). We now report a survey of 13 synthetic peptides with the general sequence XHRPYam, all tested with regard to their ability to delay fibrinolysis in an in vitro system activated by t-PA, the results being used as measures of binding affinity to the betaC hole. Unexpectedly, some large and bulky amino acids, including methionine and arginine, are effective binders. Amino acids that branch at the beta carbon (valine, isoleucine, and threonine) do not bind effectively. Crystal structures were determined for two of the peptides (GHRPYam and MHRPYam) complexed with fibrin fragment D-dimer; the modeling of various other side chains showed clashing in the cases of beta-carbon substituents. The two crystal structures also showed that the enhanced binding observed with pentapeptides with carboxyl-terminal tyrosine, compared with that of their tetrapeptide equivalents, is attributable to an interaction between the tyrosine side chain and a guanidino group of a nearby arginine (beta406). The equivalent position in gamma-chains of human fibrin(ogen) is occupied by a lysine (gamma338), but in chicken and lamprey fibrin(ogen), it is an arginine, just as occurs in beta chains. Accordingly, the peptides GPRPam and GPRPYam, which are surrogate A-knobs, were tested for their influence on fibrin polymerization with fibrinogen from lamprey and humans. In lampreys, GPRPYam is a significantly better inhibitor, but in humans, it is less effective than GPRPam, indicating that in the lamprey system the same tyrosine-arginine interaction can also occur in the gamma-chain setting.
About this Structure
2Q9I is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini., Doolittle RF, Pandi L, Biochemistry. 2007 Sep 4;46(35):10033-8. Epub 2007 Aug 10. PMID:17688324 Page seeded by OCA on Sun May 4 14:34:43 2008